Crane Holdings Co (NYSE: CR) Q1 2026 Earnings Call dated Apr. 28, 2026
Corporate Participants:
Allison Poliniak-Cusic — Vice President of Investor Relations
Alex Alcala — President and Chief Executive Officer
Rich Maue — Executive Vice President and Chief Financial Officer
Analysts:
Amit Mehrotra — Analyst
Matt Summerville — Analyst
Jeff Sprague — Analyst
Justin Ages — Analyst
Scott Deuschle — Analyst
Myles Walton — Analyst
Nathan Jones — Analyst
Jordan Lyonnais — Analyst
Presentation:
Operator
Welcome to the Crane Company First Quarter 2026 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode and the floor will be open for questions following the presentation. If you’d like to ask a question at that time, please press star one on your telephone keypad. If at any point your question has been answered, you may remove yourself from the queue by pressing star 2. So others can hear your questions clearly, we ask you pick-up your handset for best sound quality. Lastly, should you require operator assistance, please press star zero. I would like to now turn the call over to Allison Polniak, Vice-President of Investor Relations. Please go-ahead.
Allison Poliniak-Cusic — Vice President of Investor Relations
Thank you, operator, and good day, everyone. Welcome to our first-quarter 2026 earnings release Conference call. I’m Alison Poliniak, Vice-President of Investor Relations. On our call this morning, we have Alex, President and Chief Executive Officer; and Rich Maui, our Executive Vice-President and Chief Financial Officer; along with Jason Feldman, Senior Vice-President, Investor Relations, Treasury and Tax, who is on for Q&A. We will start-off our call with a few prepared remarks from Alex and Rich, after which we’ll respond to questions. And just a reminder, the comments we make on this call will include forward-looking statements.
We refer you to the cautionary language at the bottom of our earnings release and also in our annual report, 10-K and subsequent filings pertaining to forward-looking statements. Also during the call, we will be using some non-GAAP numbers, which are reconciled to the comparable GAAP numbers in tables at the end of our press release and accompanying slide presentation, both of which are available on our website at www.craneco.com in the Investor Relations section. Now let me turn the call over to Alex.
Alex Alcala — President and Chief Executive Officer
Thank you, Alison, and good morning, everyone. We appreciate you joining us today. As I step into the role of CEO, I’m energized by the opportunity to leave Crane at a time with strong leadership, disciplined execution and agility truly matter. Much like this time a year-ago, we are operating in an environment that continues to evolve rapidly. Fortunately, our business system, the CBS machine, together with our global team’s relentless focus, resilience and commitment to execution with a disciplined cadence continues to differentiate Crane. We view periods of uncertainty and market dislocation not as obstacles, but as opportunities to elevate our performance. Time and again, Crane has emerged from challenging environments stronger than before and increasingly advantaged relative to our competitors. And we’re off to a strong start in 2026. With first-quarter results reflecting excellent execution across the company, exceeding our expectations and underscoring the strength of our teams and our commitment to delivering shareholder value. Adjusted EPS of $1.65 was up 15% over the prior year, driven by 4% core sales growth, reflecting broad-based strength at Aerospace and Advanced Technologies and continued strong execution at Process Flow Technologies, including solid core order and backlog momentum.
Also of note was the strong performance of our recent acquisitions that drove substantial amount of upside in the quarter relative to our expectations. Drug panometrics, and all performed exceptionally well with integration and deployment of CBS progressing ahead of plan and early benefits emerging faster than anticipated and ahead of what was reflected in our January guidance. We entered the year with positive momentum at both AAT and PFT. As the first-quarter progressed, our execution further strengthened our confidence in the underlying earnings trajectory for the year. At the same time, however, the external environment became more challenging, geopolitical dynamics are evolving and macroeconomic uncertainty is still very much part of that backdrop.
Taking all of this into account our performance to date and the range of scenarios, risks and opportunities we see ahead, we are raising our adjusted full-year outlook by $0.10 to a range of $6.65 to $6.85. Our guidance reflects what we have clear line-of-sight to and high-level of confidence in delivering, even against a more uncertain macro backdrop. And it assumes continued elevated energy prices and inflation through the balance of the year and already factors in potential decline in commercial aftermarket. In addition, as you would expect, our teams have actions to get ahead of the increased inflation as we move through the year. We remain focused on execution, continuing to build-on our momentum and finding potential opportunities to overdeliver. Across the organization, we continue to stay agile in a dynamic environment. Our deep management teams have been here before and we will manage with the cadence and disciplined execution that you have all come to expect from Crane. Now some thoughts on the performance of the recent acquisitions and the segments in the quarter and as we look to the balance of 2026. As I mentioned, the acquisitions performed exceptionally well.
I’m extremely pleased with the execution and pace of improvements. Over the years, we have built tremendous organizational capability that has enabled us to integrate four businesses simultaneously, at speed and with zero disruption to the core businesses. This performance reinforces the strength of CBS and the opportunity to create meaningful shareholder value through continued disciplined inorganic growth combined with the power of the CBS machine. The teams are energized, having fun and are driving results better than our expectations at the start of the year. Strong operational execution, restructuring cost actions and early commercial excellence momentum drove a majority of the upside relative to our January guidance, reinforcing our confidence in both the quality of the businesses and our integration playbook. Margins across the acquired businesses were substantially improved from last year and ahead of our plan. And we see opportunity for continued progression in the quarters ahead. More specifically, we now expect the margin and earnings contribution from the acquisitions to be more evenly weighted throughout the year compared to our prior expectation of back-half weighted performance. Based on what we’re seeing today, we now expect accretion for the full-year to be at least double what we communicated in January or about $0.15 of EPS. And my confidence in exceeding our target ROIC by year five has only increased over the last few months. I’m so proud of all our new associates that have joined Crane this year, and I’m excited to see where we will continue to take these outstanding brands in the future.
We are already moving beyond just the tactical integration actions and are well on our way with strategy deployment, painting a very exciting future for everyone, including our shareholders. Turning to Aerospace and Advanced Technologies. We continue to see strength across the aerospace and defense demand environment. The backlog we built along with the new programs and opportunities our aerospace and advanced technology teams have secured continue to provide us with great visibility well beyond 2026. Looking to the balance of the year, we continue to expect full-year core sales growth for the segment to land at the high-end of our long-term 7% to 9% range. On the commercial side, OE activity remains healthy with Boeing continuing with strong production rates. Commercial aftermarket revenue was down as expected in the quarter due to unfavorable year-over-year comparisons, while commercial aftermarket orders were up 11% in the quarter. While we haven’t seen an impact to orders at this time, given the geopolitical situation, elevated oil prices and long-haul travel disruption through the Middle-East, we could see an impact to commercial aftermarket as the year progresses. However, even factoring in a decline in commercial aftermarket, we remain confident in our 7% to 9% sales growth range, leveraging at 35% to 40%. Rich will provide more details on how we’re thinking about this. On the defense side, a lot of activity and interesting industry announcements over the past few weeks. Procurement spending remains solid and there’s a continued focus on strengthening the broader defense industrial base given the heightened global uncertainty we continue to see.
We are seeing significant demand signals across both missile defense and radar applications among other areas in our portfolio, further strengthening the long-term outlook with the potential for some benefit this year depending on order timing and lead times. In the quarter, we received strong orders for the PAC-3 program and remain under negotiations for similar wins. Additionally, we received incremental orders for LTAMS and are currently under negotiations for additional contracts with other providers.
We fully anticipate additional orders in these two defense growth areas as we move through the year. And beyond this, we continue to develop new technologies, win new business and pursue additional opportunities across this segment that gives us confidence we’ll deliver above-market growth for the rest of the decade. Particularly on the defense side, we expect replenishment of military aircraft spares and missiles along with continued demand for ground-based radar systems, all extending the period of strong demand for years. Very confident for yet another outstanding year at Aerospace and Advanced Technologies. At Process Flow Technologies, another solid quarter and we remain well-positioned to consistently outgrow our markets across the cycles. We have deliberately repositioned the portfolio around core end-markets, pharmaceuticals, wastewater, cryogenics, chemicals and nuclear power, where we hold strong competitive positions and differentiated capabilities that support sustainable market outperformance. Overall, demand for the quarter came in slightly ahead of our expectations and execution was strong, driving a 50 basis-point improvement in adjusted margins even with the dilutive impact of acquisitions. On the order side, power generation remained a key area of strength.
We also saw solid project activity in pharma tied to US capacity expansions, continued momentum in Cryogenics driven by capacity needs within the Space Launch segment and strong orders in LNG. In nuclear, as part of the palace restart, we’re able to add value by extending contract terms. With respect to the ongoing conflict, note that only about 5% of PFT segment sales are directly exposed to the Middle-East. While we’re continuing to ship today and overall demand in the region in the quarter was on-track, we do see projects moving to the right and potentially impacting the balance of 2026, along with some shipment lane disruptions. Notably, we’re not seeing cancellations. Longer-term, we do see incremental opportunities for rebuilding as the geopolitical environment stabilizes. And even with this uncertain backdrop, we continue to invest for long-term growth through disciplined execution of our multi-year technology and new product development roadmaps, along with ongoing commercial excellence initiatives, all supported by strong and consistent operational execution. Tactically, we have proven our ability to respond quickly to changes in-demand. We will remain nimble through this period, taking appropriate pricing and cost actions as-needed. For the full-year, we still expect core growth to be consistent with our initial guidance of flat to low-single digits, leveraging within our target range of 30% to 35%.
In summary, a really solid start. Our strategy is unchanged and we remain focused on managing through any near-term demand variability without losing sight of our long-term objectives. Taken together, our businesses remain exceptionally well-positioned to continue delivering strong results. We also continue to see significant opportunity to further enhance performance through acquisitions. Our balance sheet remains exceptionally strong with substantial available M&A capacity and we continue to pursue a robust pipeline of potential opportunities. M&A activity has not slowed and we are actively engaged on a number of opportunities across both aerospace and advanced technologies and process flow technologies.
While there is nothing imminent at this point, our pipeline remains healthy and we remain disciplined and selective as we evaluate potential transactions. Before turning the call over to Rich, I want to emphasize that while external conditions remain dynamic, our focus has not changed. We remain disciplined in the areas we control, execution, customer focus, cost-improvement, development in our people and continued investment in our growth initiatives and technology roadmaps. We believe this approach positions Cranes to outperform our end-markets and create long-term shareholder value. Regardless of near-term volatility over the long-term, our approach remains consistent. We will deliver a 4% to 6% long-term core sales growth through the cycles from resilient and durable businesses with solid aftermarket. Substantial operating leverage on-top of already solid margins today that should lead to double-digit average annual core profit growth with significant upside from capital deployment.
Now let me turn the call over to our CFO, Mr Rich Maui, for more specifics on the quarter.
Rich Maue — Executive Vice President and Chief Financial Officer
Thank you, Alex, and good morning, everyone. Wow, what a start to the year. Let me start-off with total company results. Total sales were up 25% in the quarter compared to last year with 4% core growth, driven primarily by the ongoing strength within the Aerospace and Advanced Technologies segment. Sales from acquisitions contributed 18% in the quarter, which was modestly above expectations, reflecting strong execution as these four new businesses become a part of the Crane machine. Adjusted operating profit increased 29%, reflecting the impact of the higher core sales, contribution from the acquisitions and productivity and favorable price net of inflation, a truly outstanding result. And total core FX-neutral backlog was up 9% compared to the first-quarter last year, reflecting continued strength at Aerospace and Advanced Technologies and core backlog was up 3% sequentially, driven primarily by Process Flow technologies. Core orders were down 5% year-over-year, but were modestly better than we expected. The decline was entirely driven by an unfavorable comparison within Aerospace and Advanced Technologies, where a 15% decline reflected the record first-quarter orders last year in this business, which included several multi-year orders that we highlighted to you last April.
Core orders in PFT increased 5% compared to last year and core backlog in PFT was up 7% compared to December. Backlog and orders across the acquisitions were also solid coming in modestly above our expectations and continuing to support a strong full-year outlook. From a balance sheet perspective, we ended the quarter with pro-forma net leverage at 1.4 times, leaving us well-positioned for further M&A as Alex noted. A few more details on the segments in the quarter. Starting with Aerospace and Advanced Technologies. Sales of $318 million increased 28% in the quarter with core sales up 9.4%. Our backlog of nearly $1.2 billion increased 14% on a core basis and increased 24%, including. On a sequential basis, core backlog increased 2% with total backlog up 11%.
Again, no surprises and at record levels. Demand remains strong. We are seeing increasing RFP and RFQ activities across several defense programs supporting missile defense and ground-based radar, some of which reflect recent wins at some of our defense customers giving us further confidence in our multiyear outlook. Let me spend a minute on the core business in the quarter. On the OEM side, sales were strong, up 16% with commercial OEM up 20% and military up 10%. Total aftermarket was down 2% in the quarter with military aftermarket posting a very strong increase, up 28% in the quarter, reflecting the breadth and strength of our portfolio. That military strength was offset by commercial aftermarket, which was down 13% as expected. Specific to commercial aftermarket, shipments were largely in-line with what we expected for Q1, but with an unfavorable comparison against higher initial provisioning in the prior year first-quarter. Even with that decline, we came in above our growth expectations for the quarter. Of note, commercial aftermarket orders in the quarter were up 11% year-over-year and 10% sequentially. While we haven’t seen any impacts to orders so-far resulting from the ongoing conflict, elevated oil prices and disruptions to long-haul travel through the Middle-East could create pressure on commercial aftermarket as the year progresses.
We are factoring into our guidance that commercial aftermarket could decline on a full-year basis. Taken altogether though, we remain very confident in our full-year segment sales outlook. We continue to expect total core sales growth at the high-end of our 7% to 9% algorithm. While the mix across sub-segments may shift as the year plays out, our overall guidance is unchanged and that really speaks to the diversity and durability of our Aerospace and Advanced Technologies portfolio. Adjusted segment margin of 24.6% compared to 26.2% last year, primarily reflecting the impact of the Druck acquisition. This was an outstanding result and nearly 200 basis-points better than we expected, given drug outperformance in the quarter as well as continued strong performance in our core A&E business. At Process Flow Technologies, in Q1, we delivered sales of $378 million, up 23% compared to a year-ago, with core sales down 0.6%, slightly better than we anticipated with the acquisitions of Panametrics, Reuters Stokes and Optech Daniellotte adding 19 points of growth and FX contributed 4 points of growth in the quarter. Compared to the prior year, FX-neutral backlog at PFT decreased 2.5%, but on a sequential basis improved a solid 7%. In addition, core FX-neutral orders were up 5%, also modestly above our expectations.
Adjusted operating margin of 22.1% was approximately 50 basis-points above the prior year, and this was inclusive of the dilutive impact from the recent acquisitions. And like Aerospace and Advanced Technologies, results were above our expectations given better performance across our core businesses and each acquired business. Productivity is reading through as well as price, net cost. In the quarter, the impact from the conflict in the Middle-East was nominal as Alex mentioned. We have just under 5% of total exposure in-region on a full-year basis. We expect projects to move to the right and we do expect notable freight and other inflationary headwinds as we move through the balance of 2026. Our teams are already executing to ensure no net inflation risk to the P&L, inclusive — inclusive of margin impacts. In summary, we continue to expect core operating leverage for the segment between 30% to 35% for the full-year.
Moving to the non-operational items below the segments. Corporate expense for the quarter was $24 million, slightly lower than our expectations. Recall, we anticipated corporate expense to be highest in Q1 due to accounting rules that require accelerated amortization of stock-based compensation expense for associates that are retirement-eligible. For 2026, we continue to forecast corporate expense to be in the range of $80 million to $85 million. Given the funding for the acquisitions of Druck, Reuterstokes and Optech Danulet, net non-operating expense in the quarter was $15 million and we continue to estimate full-year 2026 net non-operating expense of approximately $58 million. And lastly, we continue to expect our tax-rate for 2026 to approximate 23% taking all of this into account our performance to date as well as the risks and opportunities we see ahead, as Alex mentioned, we are raising our adjusted full-year guidance by $0.10 to a range of $6.65 to $6.85, again, reflecting what we have clear line-of-sight to and a high-level of confidence in delivering.
Looking at the cadence of quarterly results for the year, we expect Q2 to be similar to-Q1 and our full-year earnings split to now be more balanced at around 49% to 51% between the first and second-half given the strong Q1 performance. The second-half earnings performance is expected to be more evenly balanced relative to our historical quarterly cadence of a sequential decline from Q3 to Q4, given the expected performance of our recent acquisitions. We began the year with performance that exceeded our expectations, underscoring the strength of our teams, our strategic direction and our execution. We remain committed to building on that momentum and consistently delivering results. You know, Alex, all the uncertainty that everyone is talking about this earning season reminded me of a notable quote from the Academy Award-winning actor Ryan Reynolds from the timeless movie classic National Lampoon’s Van Wilder. Worrying is like a rocking chair. It gives you something to do but it doesn’t get you anywhere at Crane, leveraging our CBS machine we are very intentional and focused on what’s in our control, no matter what the environment and we always view periods of uncertainty as periods of opportunity. And with that, operator, we are now ready to take our first question.
Questions and Answers:
Operator
Thank you. The floor is now open for questions. At this time, if you have a question or comment, please press star one on your telephone keypad. If at any point your question is answered, you may remove yourself in the queue by pressing star 2. Again, we ask you pick-up your handset when posing your questions to provide optimal sound quality. Thank you. And we’ll take our first question from Amit Mehrotra. Please go ahead; your line is open.
Amit Mehrotra
Thanks, operator. Good morning. I wish I had a good movie quote, but I’ll have to come up with one next quarter. Maybe starting — maybe starting with the progress you’re making on PSI, which is obviously very, very strong and clear. Maybe just unpack where the upside is coming from across drug,, stokes. And obviously, you’ve had this target of getting from $60 million to $150 million over five years to hit that ROI target. It seems like you’re achieving that greater or even faster. Maybe you can just update us on timing with respect to that progression.
Alex Alcala
Yeah, good morning, Amit. Thank you for the question. So related to PSI, the quarter upside, I mentioned three areas. First, the execution of the three businesses was stronger-than-expected. Just from a volume standpoint, demand and stronger execution has been very solid. So that created some upside. The cost actions, you may recall that we’re taking two types of cost actions in the short-term. One is eliminated the overall PSI layer management layer. We’re really operating these as three businesses.
So that was executed very well. And then within the businesses, as we’re executing product-line simplification, there’s realignment also resources and restructuring. So we moved — teams moved quite quickly in the quarter and we started to see some of that upside. And then the third element is the beginnings of value pricing and commercial excellence that are starting to read-through as we move to also a great speed and expect that to improve during the year. Related to timing overall, so this year, we came in thinking on the top-line, the PSI set of businesses would be in the range of 4% to 6% on the growth. We’re now thinking closer to the higher side of that range. And we were thinking we would improve 200 basis-points of margin and now we’re thinking at least 300 basis-points of margin. So ahead of schedule of our of our plan, which puts us overall in that five-year timeline really gaining ground. So very confident in over-delivering to those benchmarks.
Amit Mehrotra
Great. Great. Thank you for that. And just maybe as a follow-up, can we talk about PFT core order improvement, obviously, very, very strong sequentially. Is it enough to sort of call an inflection in the process flow cycle where you’re seeing the strongest momentum across obviously, you’re various regions and various end-markets.
Maybe you could just double-click on that in terms of what you’re seeing that momentum?
Alex Alcala
Yeah. So on the question of orders for PFT, the strength has come in some markets that we’ve been highlighting in the past has continued. I think that will continue through the year. So power, power generation in Americas, pharmaceuticals, cryogenics, wastewater, in particular gave us the upside. So that’s been pretty consistent. Interestingly, we don’t see those segments impacted by the higher energy prices. So we think demand will remain solid through the year. Chemical has continued to be sluggish at a trough holding, but I wouldn’t Call-IT a — an inflection point yet until we see that piece of the business changing. Now historically, higher energy prices has led to increased demand in that chemical segment, but it takes a while to read-through and particularly in the Gulf, where we see — the customers see that benefit of feedstock between gas and oil. And even though in-demand and customer demand for their customers may be slower, it still makes sense to invest and expand capacity debottlenecking and so forth. So I think solid, not quite calling an inflection, especially on the chemical, but definitely better than we expected going into the year and feel better about the prospects that we did three months ago.
Amit Mehrotra
Great. All right. Thank you very much. Congrats on the good results. Appreciate it.
Alex Alcala
Thank you. Thank you, Matt.
Operator
Thank you. We’ll take our next question from Matt Summerville of D.A. Davidson. Please go-ahead. Your line is open.
Matt Summerville
Thanks. A couple of questions. Can you maybe comment on the magnitude of EPS accretion you witnessed as it pertains to the acquisitions and specifically what you’ve done to drive near immediate linearity in those businesses, which last conference call were sort of deemed to be quite second-half load — back-half loaded overall? And then I have a follow-up.
Rich Maue
Great. Yeah. So we obviously did see some accretion in the quarter, as Alex mentioned. We felt just given the results that we feel like we’re going to see at least double what we thought on a full-year basis. So coming into the year, we were had in our minds about an $0.08 number in mind and we felt comfortable today saying that we would see a full-year of $0.15. So we did see a portion of that here in the first-quarter. And I wouldn’t say it’s necessarily linear, but perhaps close. And so that would be — that would be the overall impact and how we’re feeling about the business. If that helps.
Alex Alcala
Yeah. I think to add, Matt, on the cost actions that we took, we were able to execute faster than we had originally planned. So that creates not only upside for the year, but also more balanced earnings through the year. Now that said, as some of this backlog with improved pricing reads through, we’ll still expect to see some gradual improvements on the acquisition as the year progresses.
Rich Maue
Yeah. The only other thing I would add is that you saw — we saw more — a little bit more in the way of, I think as we think about the cadence, the volumes have been a bit stronger as well, in particular for — in particular for drug?
Matt Summerville
Understood. Thank you for that. And maybe, Alex and Rich, if you can expand just on kind of the actionability you’re seeing in the M&A pipeline, maybe handicap a bit whether you see more deals getting over the finish line before the end-of-the year into the early part of ’27? And if the average deal size you’re looking at is starting to kind of melt higher similar in maybe more similar in nature to you know, the size of PSI as an example.
Alex Alcala
Yeah, Matt, so deal activity or M&A opportunities continues to be quite strong. There’s a lot of happening. We’re involved in several processes on both sides of the segment. It’s a range of sizes. I think we’ve commented before that our sweet-spot is around that $500 million of value and — but there’s deals that are smaller than that we’re looking at that seem quite interesting as bolt-ons and there are some deals that are a little bit bigger than that also look interesting. So it’s a bit opportunistic. We’ll remain disciplined. So we’ll see how the year plays out. But as far as activity and focus, there’s quite a bit happening. Do you have anything, Rich?
Rich Maue
No, I think that sums it up. The nature of the transactions too, I would say from a complexity and bandwidth perspective, everything we’re looking at is on — nothing is going to cause us to hesitate in the way of resource constraints.
Matt Summerville
Understood. Thank you, guys. Thank you.
Operator
We’ll take our next question from Jeff Sprague with Vertical Research. Please go ahead; your line is open.
Jeff Sprague
Hey, thanks. Good morning, everyone. Hey, just wanted to come back to the comments about aero aftermarket and completely understand it could sort of fade as the year progresses given what’s going on. But it’s a little unclear what you’re actually doing with your guidance. Are you sort of saying, yeah, it could be weaker, but we can make it up elsewhere? Or have you actually dialed in a decline in aftermarket in the way you’ve guided the year here? Yeah. But yeah. Yeah.
Rich Maue
Thanks, Jeff. So I think maybe a little perspective to start as well on this. So if you remember, when we came into the year and we initiated — initially issued our guidance for commercial aftermarket, we were, I would say on the lower end of perhaps what the rest of the industry was projecting, right? We were saying something like in the mid-single-digit range coming in and we did get a lot of questions. We did get a lot of questions back on that. And here we are a quarter later and we see the headwinds in the marketplace potentially from the Middle East, the conflict and so forth. And we’re basically saying here, you know, we’re going to guide down.
So our guidance reflects a down — a down number for commercial aftermarket. Now, when you consider what our initial guide was, the move and you guys can all do the math, right, it isn’t a big number overall. And then in terms of offset, what we are seeing is a pretty considerable demand increase in our view, potentially in — I would say, we are seeing in military. In particular, in spares, aftermarket you saw in the quarter, we were up 28%. We have the incremental benefit that comes in the second-quarter through the balance of the year in the F-16 brake control upgrade program I think you’re aware of. So when you look at — when you step-back and you just look at the overall complexion of our aftermarket and where we’re coming from off the first guidance number that we put out in January, we feel highly confident that we’re going to offset even in this revised down outlook for commercial aftermarket.
Alex Alcala
How plays out differently, Jeff, right, because aftermarket demand has been resilient post-COVID, as you know, to higher energy and travel has been resilient. But if it plays better than our assumption, then that’s an opportunity for us, an upside. But we felt comfortable assuming a more conservative view because we have the offsets already line-of-sight in our backlog?
Jeff Sprague
Yeah. No, great. I was just unclear if you had formally dialed it in or you were just saying you had contingency to deal with it that happened. So Rich, very clear answer there. I appreciate it. And then on just back to PSI, to what degree have you seen just maybe the commercial front-end of the business change? In other words, very good businesses, right, but orphans, so to speak, inside a larger organization. So maybe just a little bit of color on what’s happening on the customer side, are you seeing better order intake or inquiries in some of those businesses than you might have otherwise expected or again is the upside more about — and accounts, obviously, but it’s more about the pricing and some of the cost actions that you already elaborated on.
Alex Alcala
Yeah, Jeff. So what we’re seeing right now on the commercial side, there’s been significant changes on how we operate, which projects we go after, how we go after them.
So I would say we’re being more successful in winning the target projects that are more interesting and more profitable for us very quickly. And also around just our pricing practices, value pricing, those would be the primary areas where we’re starting to see differences. So we had this long period, as you recall, six months-to really prepare ramp-up and those areas we’ve been able to impact shortly. Now, we’re starting to work the strategies of longer-term growth, which were never baked into our model.
And so now we’re shifting focus into that and we think there’s upside even to the numbers that we talked about as those initiatives develop?
Jeff Sprague
And maybe just a quick unrelated one. Plenty of capacity in your defense businesses for these missile-related ramps and the like or we should expect some more capacity in the ground to ride this wave.
Alex Alcala
Yeah, we have plenty of capacity. Actually, Rich and I just did a deep-dive review with the team a few weeks ago. We’re very well-positioned for that. I think the pacing item in the industry will be more than the primes. We can significantly outpace the ramp-ups of the manufacturers of the actual missiles. So we’re in pretty good shape there.
Jeff Sprague
Great. Thank you.
Operator
Thank you. We’ll take our next question from Justin Ages with CJS Securities. Please go-ahead. Your line is open.
Alex Alcala
Hi, Justin.
Justin Ages
Hi, good morning all. You mentioned chemicals still sluggish holding at trough levels and I just want to know-how that fits into the broader commentary that you gave about seeing some PFT projects being pushed out. Is that chemical being pushed out or those have already been pushed out? So no change in the timeline there.
Alex Alcala
Yeah. The push-outs that we commented on were specific to the Middle-East dynamic. And it’s really related to the conflict where some of the petrochemical areas or refineries have been shut-down temporarily. So some of that activity has pushed out to the ride, no cancellations. So that’s very unique to that region and that conflict. Now here as we started Q2, we started seeing those things starting to move a little bit faster than I thought they would.
So that said, in our guidance, we did factor in some delays in projects in that region, Middle-East in our guide from a conservative standpoint. If it moves faster, then again, it will be a positive for us. Yeah. More broadly, you know, in chemical, again, higher oil prices, we expect the Gulf at some point to see some momentum in projects that will take several quarters. We are starting to see a little bit of MRO activity pickup, particularly in the Americas, which usually precedes project investments later in the year going into next year, what would be our expectation?
Justin Ages
Thanks for that, Alex. And then staying in PFT, you mentioned a good performance in cryo. Can you just remind us or give us some color on the size of that space and the market opportunity there?
Alex Alcala
Yeah. So our crowd business today is about 4% or 5% of total PFT, but it’s growing at mid-teens, 15, 16, 17. So it’s growing quite fast. It’s mainly Americas based servicing very high-growth markets like space launch or commercial space launch, as you know, is increasing significantly. So supporting that launch platform, not on the actual rockets or aircraft, but on the launch is where we’re seeing a lot of demand supporting general aerospace, environmental testing. So as aerospace keeps ramping up, the investments in infrastructure for testing, pharmaceuticals and other areas, semiconductors as well. So very, very interesting markets, high-growth and growing at a fast pace. So this is an area that has been part of our transformation. We basically went from zero a few years ago to 4% to 5% now, combination organic and inorganic actions.
Justin Ages
That’s great. I appreciate you taking the questions. Thank you.
Alex Alcala
Thanks.
Operator
Thank you. We’ll go next to Scott Deuschle with Deutsche Bank. Please go ahead; your line is open.
Scott Deuschle
Hi, good morning. Alex, what are the most PMI-sensitive parts of PFT are you seeing any uptick in-demand in those PMI sensitive businesses or is it more just areas like pharma and and nuclear?
Alex Alcala
I mean our biggest uptick has been power generation, which is right now driven obviously by the investment in data centers that has not, I think, been PMI related pharma, cryo, wastewater. We did see pretty solid just industrial activity in the quarter. We didn’t Call-IT out, but it was a little bit stronger than we expected going into the year.
Rich Maue
Yeah. I would have said general industrial portion as well of the market where we are seeing a little bit of improvement, Scott. That helps. Okay.
Scott Deuschle
I think you all have described PFT as being pretty early cycle. So if the broader industrial cycle is turning as the PMI — PMI data suggests, I guess, why would it just be a small benefit to your general industrial business?
Alex Alcala
Well, I mean, it was low — it was mid-single-digit type activity that we saw there, right? So in the industrial spaces, that’s a pretty healthy activity. We’ll see how all things progress. But it was — we’re pretty pleased with how it started the year.
Scott Deuschle
Okay. And then, Alex, how large is the product-line for Crane today? And if it’s not material now, I guess, could it be become — could become material if it grows 200%.
Alex Alcala
I mean we look at we look at that whole missile platform, right, which is the number I have in my head, it’s around that $30 million to 40 million range of Mike, of microwave and modular power product lines. And so I would use that $30 million to $40 million jump-off point and the projections are from 2x to 4x, 5x growth from now to 2030.
Scott Deuschle
Okay. And then lastly, I say, oh, go-ahead.
Rich Maue
Yeah. PAC, PAC-3 would be towards the top-end of the programs. We have maybe 12 or so programs that we’re watching closely and that would be one of the ones that are at the top, Scott?
Scott Deuschle
Okay. Thank you. And then Alex, can you give us a sense as to how much of PFT’s cryo sales are related to the space market? And will that space growth within cryo? Is that going to correlate with SpaceX’s launch cadence over the coming years?
Alex Alcala
Yeah. On the space launch, it’s about 35%. So it — and then you put in aerospace in general, now you’re looking more like 45% and the balance is other industrials, like I said, pharma and so forth. But the growth does correlate with the launch activity, which is increasing, but not only SpaceX, but the other companies like Blue Origin and so forth. So we service, I think there are six or seven key customers of ours in that space launch and it’s growing exponentially in-line with the space launch activity.
Scott Deuschle
Thank you.
Operator
Thank you. We’ll take our next question from Myles Walton with Wolfe Research. Please go-ahead. Your line is open.
Myles Walton
Thanks. Good morning. I was wondering if on the commercial aftermarket comments that whether or not you are reducing the outlook there because of what you’re seeing or because of what you anticipate seeing? And if you can give us any clarity or color as it relates to recent bookings trends, the 11% growth in orders versus the 13% declines in the quarter wouldn’t suggest you’re seeing much, but maybe just add color if again, you’re doing this based on what you’re seeing or what you anticipate you’ll see.
Alex Alcala
Yeah, I’ll comment first and then Rich can add. But I mean, if you look historically, right, over the last 15 years, high-energy prices pre-COVID and post-COVID are two different stories. Pre-COVID, it was a pretty strong correlation of higher energy prices, higher airfare, lowered lower activity demand. Post COVID, we saw a big spike in energy prices in the 2022 with the Ukraine conflict and it was very resilient. There was no — no slowdown from there. So we’re not sure what is going to happen. We have not seen any decline. As Rich mentioned, 11% up and we’re also sequentially up.
However, as we look-forward and considering the industry general concerns, we wanted to think through a range of scenarios that would give us a lot of confidence in our guide. So based on that, we assume the decline in our guide to have really, really high confidence. But it could maintain, it could sustain and that would just be upside for us. You add it, Rich?
Rich Maue
No, I think that sums it up, Miles.
Myles Walton
Okay. And relative to the decline, you’re thinking like mid-single-digit positive was before and now you’re sort of conceptually thinking that single-digit decline is what you’re baking in from a conservative viewpoint. Is that right?
Rich Maue
Yeah, I think that’s fair.
Myles Walton
Okay. All right. Great. And then on PFT, just as it relates to core growth, as you look to the rest of the year, given the strong orders in the first-quarter, are you able to see the turning to get to low-single digit positive organic growth or core growth for TST in the second-quarter.
Alex Alcala
I think for the year, we’re still expecting flat to low-single digits. I think for the quarters, yeah. I think we’re — second-quarter may be a little bit consistent with Q1, right? I would think about this.
Rich Maue
Yeah. I would think if you’re looking at just sequentially, think of it as you know not that different from Q1 into Q2 sequentially, Miles, without having the FX and in front of me and — but that’s the way we’re thinking about the overall absolute number.
Myles Walton
Okay. And then just one last one. What is the downward pressure on margins for the rest of the year versus the ‘232 you did in the first-quarter.
Rich Maue
The downward pressure. So we mentioned on the call that increased — we’re definitely going to be seeing and aren’t starting to see the inflation on commodities as well as well as freight. You know, earlier in the year, you have a backlog that you’re getting through and but so just from a timing perspective, we see the opportunity to get more price to offset as we move through the balance of the year and we get through that backlog. So that pressure is — I would say it’s a modest, but something that we’re working through and comfortable with overall and suggesting an increase net to the margins.
Alex Alcala
So for the full-year, improved margins versus
Rich Maue
About half — yeah, we’re saying about — I think 0.5 point improved overall margin profile.
Myles Walton
Yes, sorry, I was just comparing the first-quarter versus the implied next 3/4 is the next 3/4 are obviously slightly down versus the first-quarter on the 23%. Yeah.
Rich Maue
Well, I think, again, it gets to — it does get to some of that inflation — it’s basically the same answer, right? I’m going to see some inflationary pressure. I’m going to cover some of it. Net-net, I’ll be at up 50 basis-points — the 50 basis-points. But yeah, it’s going to be that inflationary pressure miles.
Myles Walton
Got it. All right. Thank you.
Rich Maue
Yeah.
Operator
Thank you. We’ll take our next question from Nathan Jones with Stifel. Please go-ahead. Your line is open.
Nathan Jones
Good morning, everyone. Good. I’ll do — I’ll do a couple on the acquisitions. Alex, you talked about moving to the strategy deployment phase on the acquisitions. I think you talked about — talked a little bit about shifting the focus to growth initiatives. Hoping you could maybe provide a little bit more color on what that involves for each business?
Alex Alcala
Yeah. So when you think about — again, just to be clear, Nathan, none of this was baked into our model, it’s all upside. But if you think about drug, some of the opportunities we saw were military defense has — drug has a pretty good position in Europe and not really any position of note in the United States defense, where our legacy aerospace and defense business has strength. So we’re building up the strategies of how to create those synergies and create growth.
There’s various regional differences in penetration and share also in truck, in the business, Europe, US differences, channel on channel that we are working through. So those are a couple of examples of where there’s potential growth upside. Panametrics in that business, we think about really also regional. I think we see a lot more opportunity in Americas to grow, they have a lower share in Americas than average. So there’s opportunity there in aligning those efforts from a commercial standpoint.
And then, we’ve been — we have a very, very strong position on power generation piece of nuclear, but we also have some product lines around other platforms of radiation monitoring and homeland security. So we plan to build-on those platforms as well and grow. So those are some of the things we’re thinking about from a strategy deployment standpoint.
Nathan Jones
That’s great. Thanks. My second question was going to be on the value-based pricing that you’re already beginning to realize. I think that’s a very rapid benefit there. I know some of these business — businesses have longer-term contracts. So maybe if you can talk a little bit about where you’re seeing value-based pricing, where you’ll see it in the future? And I mean, it’s obviously it’s very early in the piece so far. Just any color you could give us around that stuff.
Alex Alcala
Yeah. So the longer-term contract are probably less than you would think. If you — if you think about, about 30% of the business is on longer-term contracts. So there’s a lot of areas where we can move more quickly on the — on the right of stokes part of the business is about 40%, some of these are naturally coming up and renegotiated. And the panometrics is very, very low, a longer-term contract. So all-in all, there’s a lot of opportunities within the year and then as we continue to work the longer-term contracts. So very confident in our ability to keep improving these margins through the year and going into next year.
Nathan Jones
Thanks very much for taking the questions.
Operator
Thank you. Once again, if you do have a question, you may press star one on your telephone keypad at this time. We’ll take our next question from Ronald Epstein with Bank of America. Please go ahead; your line is open.
Jordan Lyonnais
Hey, good morning. This is Jordan on for Ron. Thanks for taking the question.
Alex Alcala
Hi, Jordan.
Jordan Lyonnais
On the — you can see — here you guys. On the balance of the year for commercial out, if we’re going to see aftermarket decline in the guide. How should we be thinking about margins for the segment? And for PFT, are you guys factoring in or having any concerns on the new tariffs that are going through on raw materials?
Rich Maue
Yeah. So on — a good question. So on the margins overall, Jordan, when you look at that mix differential, what I would say, I step-back and say, first of all, our portfolio in aerospace and advanced Technologies, when we say commercial OE, we make money on commercial OE, right? It’s — our model, as you know, is very — or perhaps different from others in the industry. So when we do mix-up and down, yes, there is some impact, but it’s not as perhaps drastic as maybe in other companies.
Specific to the commercial aftermarket, as we have that coming down in our forecast or in our guidance, when we look at what we’re seeing in military, moving in the opposite direction, the margin profiles are not that far off, frankly. They’re quite similar. So that mix change is not going to be as significant, if at all from a margin pressure point of view.
In PFT, with respect to tariffs, I would say the overall tariff change has not been all that material to us so-far in the year, or it won’t be in the year. The one area that I would point to is, you know, with the refund process, to the extent that we’re successful there, we’ll, of course call that out in-balance of the year, but none of that is factored into our guidance. No upside is factored into our guidance.
Jordan Lyonnais
Got it. Thank you.
Rich Maue
You’re welcome.
Operator
Thank you. This concludes the Q&A portion of today’s call. I would like to now turn the floor back over to Alex for closing remarks.
Alex Alcala
Thank you all for joining us today. Over the past 13 years, Crane has undergone a meaningful transformation, reshaping the portfolio, significantly improving margins and growth and delivering strong shareholder value under Max’s leadership.
That foundation positions us exceptionally well for what comes next. This transition is not a change in direction. It’s the next phase of the same journey. It’s about acceleration of profitable growth. Looking ahead, I am more excited than ever about Crane’s future and the opportunity to continue delivering for our customers, our associates, our communities and our shareholders.
We will remain focused on executing our strategy, leveraging the Crane business system to drive strong organic growth while continuing to pursue our disciplined approach to accelerating inorganic growth. I’ve had the privilege of working alongside an extraordinary team across the globe and I’m energized by the path ahead. With this team, this strategy and this portfolio, I’m confident that the best chapters of Crane are still in front of us. Thank you all for your interest in Crane and your time and attention this morning. Have a great day you.
Operator
This concludes today’s Crane Company First Quarter 2026 earnings conference call. Please disconnect your line at this time and have a wonderful day.